-transparent.png){kind=logo}
The first human tumor derived protein with in vivo angiogenic activity to be obtained in pure form has been isolated from serum-free supernatants of an established human adenocarcinoma cell line (HT-29) and named angiogenin. It was purified by cation-exchange and reversed-phase high-performance liquid chromatography; the yield was approximately 0.5 microgram/L of medium. Biological activity of angiogenin was monitored throughout purification by using the chick embryo chorioallantoic membrane assay. Statistical evaluation demonstrates that it displays activity in this system with as little as 35 fmol per egg. Moreover, only 3.5 pmol is required to induce extensive blood vessel growth in the rabbit cornea. The amino acid composition of this basic (isoelectric point greater than 9.5), single-chain protein of molecular weight approximately 14 400 has been determined. The amino terminus is blocked, and the carboxyl-terminal residue is proline.
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
August 2002,
Protein and peptide letters,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
March 1991,
Proceedings of the National Academy of Sciences of the United States of America,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
March 2007,
Biochemistry,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
August 1987,
Biochemistry,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
July 1997,
European journal of biochemistry,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
June 1988,
British journal of cancer,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
August 1992,
The Indian journal of medical research,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
September 1999,
Biochemical and biophysical research communications,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
March 1977,
British journal of haematology,
J W Fett, and
D J Strydom, and
R R Lobb, and
E M Alderman, and
J L Bethune, and
J F Riordan, and
B L Vallee
February 1989,
Journal of biochemistry,
